Mirati Therapeutics (MRTX) recebe designação de terapia inovadora da FDA para adagrasib com cetuximab
23 December 2022 - 2:07AM
Newspaper
/jornal/2022/12/mirati-therapeutics-mrtx-recebe-designacao-de-terapia-inovadora-da-fda-para-adagrasib-com-cetuximab/
Mirati Therapeutics (BOV:M2RT34)
Historical Stock Chart
From Sep 2024 to Oct 2024
Mirati Therapeutics (BOV:M2RT34)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Mirati Therapeutics Inc (Brazil Bovespa Exchange): 0 recent articles
More News Articles